Temporal aspects of the action of ASA404 (vadimezan; DMXAA).
Temporal aspects of the action of ASA404 (vadimezan; DMXAA).
复制标题
DOI:
10.1517/13543784.2010.529128
复制
发表时间:
2010-11
影响因子:
6.1
通讯作者:
Siemann DW
中科院分区:
文献类型:
--
作者:
Baguley BC;Siemann DW
ASA404, a flavonoid tumor-vascular disrupting agent (Tumor-VDA), is in clinical trial for the treatment of non-small cell lung cancer. Its action differs from both that of the tubulin binding class of Tumor-VDAs and antiangiogenic agents. In mice, ASA404 induces a sequence of changes in tumor tissue, starting within one hour with increased vascular permeability, increased endothelial apoptosis and decreased blood flow. Later effects include the release of serotonin, induction of tumor necrosis factor and other cytokines and chemokines, as well as induction of nitric oxide. This cascade of events induces sustained effects on blood flow, tumor hypoxia, vascular failure, inflammatory responses and, in some tumors, complete regression. One feature of the action of ASA404 against murine tumors is its ability to potentiate the effects of radiation and a variety of chemotherapeutic agents. The flavonoid class appears to be unique because of its dual action on vascular endothelial function and innate immunity. The translation of preclinical to clinical results demands an understanding of both the mechanisms underlying the dual effects and the species differences in ASA404 activity. Clinical trials indicate that the future of ASA404 as an effective agent relies on a deep appreciation of its cellular action.
登录
查看更多内容
影响因子:
8.8
作者:
Benhamou, Ygal;Favre, Julie;Tamion, Fabienne
通讯作者:
Tamion, Fabienne
影响因子:
2
作者:
Cuschieri, Joseph;Bulger, Eileen;Maier, Ronald V
通讯作者:
Maier, Ronald V
影响因子:
20.3
作者:
Clauss, M;Sunderkötter, C;Risau, W
通讯作者:
Risau, W
影响因子:
8.8
作者:
Ching, LM;Cao, Z;Kieda, C;Zwain, S;Jameson, MB;Baguley, BC
通讯作者:
Baguley, BC
影响因子:
8.8
作者:
通讯作者:
--